Exabis Library

We will review the following items with respect to IBD:
1. History & epidemiology
2. pathogenesis 
3. genetics
4. environmental factors

1. To understand the epidemiology of IBD
2. To understand the impact of the disease on quality of life

Educational objectives: 

1. To emphasise the role of investigator-initiated studies compared to phase 3 randomized controlled trials in assessing the safety profile of IBD related treatments
2. To review the definition of real world data and the different types of real world data
3. To provide examples on investigator-initiated cohorts assessing the safety profile of IBD related treatments
4. To have an overview of the main administrative health databases used in the assessment of the safety profile of IBD related treatment

Aims of this talk are to:

     - Introduce the concepts of machine learning
     - Relay how machine learning is currently being applied in the filed of IBD
     - Present some applications using 'Omics data
     - Suggest how advancing applications might relate to treatment in IBD

To review how to manage resources when writing GRADE guidelines
To review the pros and cons of universal guidelines

1) Highlight differences in disease presenting in adolescence compared to adulthood
2) Discuss the concept of transition vs transfer and the risks
3) Review the options available for transition and tools used to measure progress
4) Discuss guidelines

Educational objectives:
1. To understand the different methods of data collection for different study designs e.g qualitative, quantitative, mixed methods
2. To emphasise the role of different types of data collection methods e.g. interview, observation, survey, etc
3. To empasise practical issues to consider when data collecting 

1. appropriate assessment
2. risk factors

 In this talk we will discuss simple yet often overlooked pearls and tips to get the most of old-school medications, focusing on thiopurines and 5ASA. We will examine which combination of topical and oral 5ASA is best in each clinical scenario, discuss the role of compliance, how to optimize technical aspects of rectal agents, desensitization and factors not to be overlooked which may contribute to recalcitrant IBD. We will also explore metabolite testing for thiopurines in clinical practice and the evidence backing its use for maintenance monotherapy 

 In this talk we will discuss simple yet often overlooked pearls and tips to get the most of old-school medications, focusing on thiopurines and 5ASA. We will examine which combination of topical and oral 5ASA is best in each clinical scenario, discuss the role of compliance, how to optimize technical aspects of rectal agents, desensitization and factors not to be overlooked which may contribute to recalcitrant IBD. We will also explore metabolite testing for thiopurines in clinical practice and the evidence backing its use for maintenance monotherapy 

1. anti-integrins
2. p19/p40 inhibitors
3. JAK inhibitors
4. positioning biologics
5. small molecules

1. To understand proper timing of surgical indication in abdominal Crohn's disease
2. To outline that delay in surgery leads to worse outcomes
3. To delineate surgical indication in perianal CD in two phases (as adjunctive to initiation of biologics and with additional procedures if persistence of fistulas after mucosal healing of the rectum)
4. To detail proper timing of surgery in acute and chronic UC